{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":97,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":97,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"a991ddcdd147","filters":{"venue":"Drug Design Development and Therapy"}},"results":[{"id":"W2593956993","doi":"10.2147/dddt.s97635","title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":488,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Muscular Dystrophy Canada; Children's Health Research Institute; Women and Children's Health Research Institute; Ministry of Advanced Education, Government of Alberta; Alberta Innovates - Health Solutions","keywords":"Exon skipping; Duchenne muscular dystrophy; Medicine; Muscular dystrophy; Dystrophin; Exon; Bioinformatics; Genetics; Internal medicine; Biology; Gene; Alternative splicing","retraction":null,"screen_n_in":null,"score":{"opus":0.1015841288865698,"gpt":0.3378670725711403,"spread":0.2362829436845706,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002696294,0.0003052538,0.0006252799,0.0000629925,0.0001121168,0.00001878819,0.000295285,0.0001934056,0.000006363508],"category_scores_gemma":[0.000007627552,0.000178261,0.0001722275,0.00004456865,0.0001045293,0.000002379821,0.0000207223,0.00006521788,0.000003528789],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001072152,"about_ca_system_score_gemma":0.0002017301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001174722,"about_ca_topic_score_gemma":0.000006941424,"domain_scores_codex":[0.9988574,0.000250263,0.0002954084,0.0003345294,0.00007576992,0.0001866738],"domain_scores_gemma":[0.9992665,0.0000409134,0.0002003461,0.000444811,0.00001912606,0.00002830146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006636751,0.0001812549,0.00001288245,0.0002383649,0.0002542945,0.000004677636,0.0004848561,5.615465e-7,0.00008470761,0.00001725652,0.0001117699,0.998543],"study_design_scores_gemma":[0.0006140072,0.0002260068,0.00008218401,0.0001926163,0.00003784572,0.000003581924,0.00003050953,3.018947e-7,0.0004702411,0.00005009731,0.9980844,0.0002082495],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007216993,0.9917557,0.00005980822,0.00001432565,0.0000597376,0.0007550484,0.00000410161,0.000003061181,0.0001312654],"genre_scores_gemma":[0.001544667,0.9973283,0.0004010446,0.0000276726,0.00006447884,0.0002638941,0.0001614287,0.00002061724,0.0001878893],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9983348,"threshold_uncertainty_score":0.7269273,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1891914108","doi":"10.2147/dddt.s84177","title":"Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Foothills Medical Centre","funders":"American Society of Clinical Oncology","keywords":"Pasireotide; Octreotide; Medicine; Gastroenterology; Internal medicine; Somatostatin; Adverse effect; Neuroendocrine tumors; Carcinoid syndrome; Refractory (planetary science); Acromegaly; Hormone","retraction":null,"screen_n_in":null,"score":{"opus":0.04525629135987289,"gpt":0.3048283482362036,"spread":0.2595720568763307,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002915725,0.0002759708,0.0005501148,0.0004126267,0.00007155183,0.00003037198,0.00009456565,0.000003126884,0.00001284863],"category_scores_gemma":[0.0001369135,0.0002071526,0.00001358376,0.0004129501,0.00006609423,0.0002242323,0.00006346576,0.0001830255,0.000004127448],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005761496,"about_ca_system_score_gemma":0.0002426429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001505529,"about_ca_topic_score_gemma":0.00006789016,"domain_scores_codex":[0.9977878,0.0002526574,0.0004936168,0.0004555457,0.0005889701,0.0004213784],"domain_scores_gemma":[0.9988588,0.0001776733,0.0001595853,0.0002264936,0.0001760113,0.0004014263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01546522,0.00541127,0.9282393,0.0001332527,0.0001966031,0.004000307,0.007592705,0.00003227893,0.000689056,0.000002185745,0.0002887951,0.03794898],"study_design_scores_gemma":[0.2588125,0.04743521,0.5567341,0.0009147707,0.0001575626,0.000467135,0.01416606,0.0002800501,0.1164324,0.00007036859,0.0029399,0.001590035],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972265,0.0004265823,0.00007526609,0.00006944102,0.00002246271,0.002108704,0.000002829362,0.00003576893,0.00003245862],"genre_scores_gemma":[0.9969729,0.00008248774,0.002361478,0.0001188509,0.000007875717,0.0001160122,0.00001978052,0.00004241232,0.0002782394],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3715053,"threshold_uncertainty_score":0.8447438,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112867551","doi":"10.2147/dddt.s90580","title":"Maraviroc: a review of its use in HIV infection and beyond","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":205,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Institute of Mental Health","keywords":"Maraviroc; CCR5 receptor antagonist; Medicine; Chemokine receptor CCR5; CXCR4; Drug resistance; Chemokine receptor; Entry inhibitor; Pharmacology; Boswellia serrata; Drug; Viral load; Virology; Viral entry; Immunology; Human immunodeficiency virus (HIV); Internal medicine; Virus; Chemokine; Biology; Viral replication; Receptor; Microbiology","retraction":null,"screen_n_in":null,"score":{"opus":0.09617880986677699,"gpt":0.3299175114230901,"spread":0.2337387015563131,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008703446,0.000317428,0.001144545,0.0002551905,0.00005860386,0.00001670155,0.0000838361,0.0002023896,0.0001033533],"category_scores_gemma":[0.00004000706,0.0002209642,0.00006794005,0.0002003049,0.00007524179,0.00009290851,0.00005375797,0.000240975,0.0001609954],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006623335,"about_ca_system_score_gemma":0.0004362643,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001435692,"about_ca_topic_score_gemma":0.000007764263,"domain_scores_codex":[0.9982427,0.0006241552,0.000496078,0.0003186892,0.00005935604,0.0002590575],"domain_scores_gemma":[0.9993572,0.0001983566,0.0001816331,0.0001459741,0.00007296958,0.00004382672],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004099874,0.000100832,0.0001301681,0.009435875,0.0003207756,0.00001096401,0.0002010743,7.566171e-9,0.00000758234,0.00002416374,0.002729642,0.9869979],"study_design_scores_gemma":[0.0009237369,0.00006654811,0.0001065101,0.01632121,0.00005680634,0.00004102934,0.000003154948,3.443557e-8,0.00011373,0.00001219029,0.9821512,0.0002038667],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000275259,0.9980192,0.00001663748,0.00002050728,0.00006020698,0.001456394,0.00002714317,0.00001405532,0.0001105826],"genre_scores_gemma":[0.00001403146,0.9969885,0.0003014093,0.0000367155,0.000005888606,0.0002685589,0.0004080003,0.00002090587,0.001956019],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9867941,"threshold_uncertainty_score":0.901066,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1692190376","doi":"10.2147/dddt.s84850","title":"Dolutegravir – a review of the pharmacology, efficacy, and safety in the treatment of HIV","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Dolutegravir; Elvitegravir; Raltegravir; Integrase inhibitor; Tolerability; Medicine; Pharmacology; Adverse effect; Integrase; Drug; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; Viral load","retraction":null,"screen_n_in":null,"score":{"opus":0.09921393294740355,"gpt":0.3656776804598496,"spread":0.266463747512446,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001543283,0.0006528621,0.002419371,0.0002140709,0.000109273,0.0000122829,0.0002768757,0.00016395,0.00005695759],"category_scores_gemma":[0.00001920186,0.000288697,0.0002616465,0.0005922088,0.0002289372,0.00003297976,0.00005012961,0.0002188111,0.00001202385],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002263721,"about_ca_system_score_gemma":0.001313556,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006236169,"about_ca_topic_score_gemma":0.000005225706,"domain_scores_codex":[0.996781,0.0007940005,0.001182588,0.0004562302,0.0004651507,0.0003210473],"domain_scores_gemma":[0.9982762,0.0005418747,0.0005348021,0.0004320616,0.0001018446,0.0001132725],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002063679,0.0009324528,0.0001540518,0.009840759,0.001022302,0.00001814193,0.005438306,4.562171e-8,0.000002201773,0.00002303332,0.006408173,0.9759542],"study_design_scores_gemma":[0.004006561,0.0001206831,0.000164641,0.02534722,0.0009558279,0.0000675263,0.00005131542,3.125064e-7,0.00008177508,0.00001610883,0.9689261,0.0002619692],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004392675,0.9922935,0.00001353199,0.001003957,0.0001115112,0.005803778,0.00001862895,0.00001505198,0.0003007168],"genre_scores_gemma":[0.00001806433,0.9929649,0.002043731,0.0002190561,0.00004918009,0.0005221568,0.0001571857,0.00004142801,0.003984283],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9756922,"threshold_uncertainty_score":0.9999565,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1991311930","doi":"10.2147/dddt.s40215","title":"Aflibercept in wet AMD: specific role and optimal use","year":2013,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Aflibercept; Medicine; Computer science; Ophthalmology; Bevacizumab; Surgery; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.09628446476675699,"gpt":0.3128199846076987,"spread":0.2165355198409417,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001435675,0.0004688021,0.001094285,0.0002258767,0.00006707437,0.0001406206,0.0000703452,0.0001485013,0.0001438941],"category_scores_gemma":[0.00000422949,0.0003170281,0.00009853394,0.0001503833,0.00005578077,0.0001141363,0.00003642415,0.0001844878,0.00008481881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007487084,"about_ca_system_score_gemma":0.000202816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002448209,"about_ca_topic_score_gemma":5.669417e-7,"domain_scores_codex":[0.9984837,0.000117706,0.0004287927,0.0004698466,0.0001975894,0.0003023369],"domain_scores_gemma":[0.9993185,0.0001168177,0.0001199021,0.0001940908,0.00002889387,0.0002218307],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009387539,0.0001658,0.0004948019,0.0005395708,0.0002316566,0.0001093875,0.0004063585,1.663138e-7,8.805541e-7,0.00001519079,0.0005440158,0.9973983],"study_design_scores_gemma":[0.001240233,0.00007923962,0.002608974,0.002520896,0.0001033456,0.00005094875,0.00004648752,0.000005789508,0.000005769017,0.00001963678,0.9929888,0.0003298723],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01116792,0.9867137,0.00003051427,0.00001400792,0.0000572335,0.001829285,0.000006198349,0.00002839912,0.0001527152],"genre_scores_gemma":[0.00009047408,0.9898113,0.005857885,0.00004035778,0.00004924828,0.0003154023,0.0001554301,0.00006018556,0.003619703],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9970684,"threshold_uncertainty_score":0.9999282,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2721615787","doi":"10.2147/dddt.s102500","title":"Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":135,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Waterloo","funders":"","keywords":"Bioavailability; Solid lipid nanoparticle; Pharmacokinetics; Pharmacology; Nasal administration; Drug delivery; In vivo; Chemistry; First pass effect; Zeta potential; Agomelatine; Chromatography; Drug; Nanoparticle; Materials science; Medicine; Nanotechnology; Antidepressant; Internal medicine; Organic chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.07019639001687886,"gpt":0.4005162602364778,"spread":0.330319870219599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007072354,0.0002497183,0.0002395952,0.0001387458,0.0005829781,0.00007887814,0.0002213954,0.0001107012,0.0002584461],"category_scores_gemma":[0.00003443791,0.000249683,0.00001777592,0.00009113731,0.0001179846,0.0003586571,0.00007231608,0.0002275957,0.000008914158],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004393012,"about_ca_system_score_gemma":0.0000609884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006865161,"about_ca_topic_score_gemma":0.00002249829,"domain_scores_codex":[0.9985166,0.0001866358,0.0003956399,0.0003665477,0.0001484793,0.000386146],"domain_scores_gemma":[0.9992173,0.0002348697,0.0001379011,0.0001587984,0.00007026305,0.0001808087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002873898,0.0004269849,0.01697546,0.00006086544,0.000271222,0.00004397641,0.0126047,0.09862194,0.4041522,0.0001566782,0.002179997,0.4616321],"study_design_scores_gemma":[0.003001829,0.00007226455,0.002778856,0.00003926786,0.00001897095,0.000004078534,0.0000705672,0.04373608,0.9000049,0.0001629809,0.04967356,0.0004367037],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9522374,0.000843804,0.04334461,0.002220308,0.000324623,0.0008215963,0.000008463549,0.00004836693,0.0001507992],"genre_scores_gemma":[0.9713541,0.003824066,0.02203179,0.00211721,0.00008809307,0.00008968424,0.000008869452,0.00002839236,0.0004578372],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4958527,"threshold_uncertainty_score":0.9999955,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2790600717","doi":"10.2147/dddt.s156724","title":"Intra-articular platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Periodontal Regeneration and Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"WOMAC; Osteoarthritis; Medicine; Platelet-rich plasma; Hyaluronic acid; Cochrane Library; Confidence interval; Meta-analysis; Randomized controlled trial; Internal medicine; Visual analogue scale; Physical therapy; Platelet; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1482357082105575,"gpt":0.3360869106164289,"spread":0.1878512024058714,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003772253,0.0005442825,0.002575299,0.0003983691,0.0001071473,0.0000494691,0.0001194426,0.0001611992,0.000196626],"category_scores_gemma":[0.000009202394,0.0002803172,0.0008847457,0.0007002956,0.00008418882,0.00004658651,0.00001133727,0.0001032627,0.00003836577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001768832,"about_ca_system_score_gemma":0.0003996769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001181146,"about_ca_topic_score_gemma":0.0000869535,"domain_scores_codex":[0.9977386,0.0003916255,0.0007352551,0.0004679374,0.0003769607,0.0002896408],"domain_scores_gemma":[0.9990083,0.0001923398,0.0002515523,0.0004016306,0.00005278309,0.00009336752],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003175808,0.0006191517,0.00001212737,0.0001836603,0.1083158,0.0001242917,0.003187006,7.590964e-7,0.000002955436,0.00001440634,0.00004363837,0.8871786],"study_design_scores_gemma":[0.006707638,0.002280947,0.00003437412,0.0001888666,0.08640504,0.00004740139,0.000108918,0.000005993085,0.002378581,0.000005196436,0.901459,0.00037807],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01351494,0.9842849,0.0000338411,0.00003839973,0.00008932561,0.001922777,0.0000114619,0.00001748575,0.00008683057],"genre_scores_gemma":[0.003699802,0.9926447,0.001409375,0.00004513823,0.00003909277,0.001166778,0.0002696944,0.00003304285,0.0006924388],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9014153,"threshold_uncertainty_score":0.9999649,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2807347319","doi":"10.2147/dddt.s166893","title":"Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Medicine; Hydroxychloroquine; Relative risk; Internal medicine; Meta-analysis; Odds ratio; Hazard ratio; Confidence interval; Randomized controlled trial; Chloroquine; Disease; Immunology; Malaria","retraction":null,"screen_n_in":null,"score":{"opus":0.1003165604679865,"gpt":0.2998698002566381,"spread":0.1995532397886517,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.005201779,0.001253153,0.01486952,0.0005742229,0.0002872284,0.0001158059,0.0002244545,0.0003504098,0.00004381992],"category_scores_gemma":[0.0003425292,0.0007226153,0.001754434,0.001377376,0.0001948749,0.000113455,0.0000968692,0.0005161845,0.00001177284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001601934,"about_ca_system_score_gemma":0.0003336255,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001466408,"about_ca_topic_score_gemma":0.00001242687,"domain_scores_codex":[0.9942099,0.001595028,0.001471768,0.001319965,0.000880006,0.0005233564],"domain_scores_gemma":[0.9963791,0.0003889631,0.001434361,0.001100767,0.0003105217,0.0003862792],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00002400733,0.0001165153,0.00001162658,0.2637983,0.7228257,0.0001068446,0.000384113,2.136383e-7,4.790113e-7,0.000001272978,0.0001028917,0.01262805],"study_design_scores_gemma":[0.001065392,0.0001074474,0.00004599869,0.05337126,0.9100078,0.000171875,0.00002416433,0.000005740313,0.00003709706,0.000005873589,0.03421281,0.000944495],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003836485,0.9918306,0.0002653736,0.00008381643,0.00002261942,0.007233874,0.00003319294,0.0001051941,0.00004169398],"genre_scores_gemma":[0.0002553655,0.995034,0.001679142,0.0002842543,0.00003736639,0.001176152,0.0001893071,0.0001413558,0.001203042],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.210427,"threshold_uncertainty_score":0.9997558,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2900391822","doi":"10.2147/dddt.s138765","title":"CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cytokine release syndrome; Chimeric antigen receptor; Context (archaeology); Medicine; Oncology; Internal medicine; Immunotherapy; Cancer; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.06862769789823206,"gpt":0.3288503921926857,"spread":0.2602226942944537,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001526875,0.001134603,0.002482185,0.0005840969,0.0004059251,0.0001763473,0.0003886833,0.0006532726,0.0005205207],"category_scores_gemma":[0.00003510341,0.0008487454,0.0004249196,0.0004291489,0.000317784,0.0001229323,0.00009775831,0.0005800917,0.00007594541],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007452839,"about_ca_system_score_gemma":0.003343939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001221717,"about_ca_topic_score_gemma":0.000002004709,"domain_scores_codex":[0.9956452,0.0004053067,0.001036027,0.0013053,0.0006625649,0.0009456179],"domain_scores_gemma":[0.9970195,0.001118568,0.0004217429,0.0007186223,0.0002478835,0.0004736546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001343906,0.0001814872,0.000007812578,0.002505432,0.001637654,0.00004989396,0.001387467,2.968532e-8,0.001089897,0.000005117549,0.006612908,0.9851784],"study_design_scores_gemma":[0.008415191,0.001080147,0.00001783819,0.002647165,0.0003506344,0.0001398233,0.00004080144,0.00001282244,0.00394208,0.00006454978,0.9823734,0.0009155481],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003153846,0.9888503,0.0007121105,0.00004215286,0.0003639463,0.006181288,0.00002696014,0.0001445099,0.0005248965],"genre_scores_gemma":[0.00005340739,0.9574713,0.005774642,0.0002747516,0.0004611357,0.001135285,0.0002823565,0.0003310518,0.03421614],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9842628,"threshold_uncertainty_score":0.9993963,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3004841311","doi":"10.2147/dddt.s232325","title":"<p>Potential Use of Microbial Surfactant in Microemulsion Drug Delivery System: A Systematic Review</p>","year":2020,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":111,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Kerman University of Medical Sciences","keywords":"Microemulsion; Pulmonary surfactant; Bioavailability; Lipopeptide; Drug; Chemistry; Pharmacology; Medicine; Biology; Biochemistry; Bacteria","retraction":null,"screen_n_in":null,"score":{"opus":0.1128185815740917,"gpt":0.3610691502098701,"spread":0.2482505686357784,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002421347,0.001295658,0.004850464,0.000495371,0.0002754915,0.00006469248,0.0008294475,0.0006186453,0.0001353],"category_scores_gemma":[0.00006234935,0.001079284,0.0005450774,0.0006824374,0.0002277998,0.0002964576,0.0002091826,0.001139968,0.0001300057],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000486602,"about_ca_system_score_gemma":0.0007980093,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006860921,"about_ca_topic_score_gemma":0.000009760663,"domain_scores_codex":[0.9902357,0.003981781,0.003266413,0.001081887,0.0005338143,0.0009003835],"domain_scores_gemma":[0.9964197,0.00104909,0.001514301,0.000474509,0.000205873,0.0003364942],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005950245,0.0004968682,0.000005360205,0.793826,0.002319062,0.0006894182,0.001607142,0.0000357947,0.003784322,0.00004817498,0.003382597,0.1932102],"study_design_scores_gemma":[0.001904308,0.00005143609,0.000001526195,0.2209034,0.002409915,0.0001360313,0.00003144613,0.0001573778,0.002250114,0.000005191051,0.7709602,0.001189082],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001003359,0.9890236,0.0006296886,0.00005198893,0.001191276,0.007814979,0.0001409629,0.000117376,0.00002677924],"genre_scores_gemma":[0.0006441013,0.9947141,0.002437594,0.000567782,0.00009452775,0.0006074188,0.0002640257,0.0001561959,0.0005142221],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7675776,"threshold_uncertainty_score":0.9999795,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2028427382","doi":"10.2147/dddt.s10812","title":"Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective","year":2010,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Medicine; C-reactive protein; Dyslipidemia; Rosuvastatin Calcium; Internal medicine; Statin; Risk factor; Disease; Inflammation; Asymptomatic; Cardiology","retraction":null,"screen_n_in":null,"score":{"opus":0.04576845898005635,"gpt":0.300191932783629,"spread":0.2544234738035727,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001753493,0.000552031,0.002092563,0.000307531,0.0001679701,0.00004843228,0.0001029378,0.0002438963,0.00001533741],"category_scores_gemma":[0.00007371676,0.0004175743,0.0007244012,0.0002704564,0.0001361976,0.0001482474,0.00005982267,0.0004765922,0.000005973262],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001871481,"about_ca_system_score_gemma":0.002023425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004498191,"about_ca_topic_score_gemma":0.000002352115,"domain_scores_codex":[0.997021,0.0004860843,0.0007414524,0.0007018399,0.000749869,0.0002997095],"domain_scores_gemma":[0.9981709,0.00006775108,0.0004135096,0.000656898,0.0003931464,0.0002977822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001813142,0.0001097423,0.000007582882,0.006806923,0.003658938,0.00001893153,0.001748042,2.596942e-7,0.00002843523,0.00007968301,0.00001646741,0.9873437],"study_design_scores_gemma":[0.001752127,0.00008844176,0.0002175991,0.006521402,0.001418265,0.00005794282,0.00007403136,8.04283e-7,0.0002828503,0.0003348486,0.9887944,0.000457284],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004430314,0.9842217,0.004386611,0.00003968914,0.00006723921,0.006677703,0.00001174075,0.00005026339,0.0001147134],"genre_scores_gemma":[0.00009315552,0.9836301,0.01395359,0.00001951784,0.0002321712,0.001166436,0.0002123301,0.00008477667,0.0006078989],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9887779,"threshold_uncertainty_score":0.9998276,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3045514455","doi":"10.2147/dddt.s262141","title":"<p>The Climate is Changing for Metered-Dose Inhalers and Action is Needed</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Action (physics); Pharmacology; Computer science; Medicine; Physics","retraction":null,"screen_n_in":null,"score":{"opus":0.07847897795096846,"gpt":0.2824976665240178,"spread":0.2040186885730493,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004935331,0.0002249424,0.0002639796,0.0001463884,0.000443222,0.00007084019,0.00006536856,0.00008550919,0.0001025247],"category_scores_gemma":[0.0000145152,0.0001572128,0.00006466395,0.0002288313,0.00006141322,0.0001250593,0.00003196297,0.0001046951,0.00002287951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003086185,"about_ca_system_score_gemma":0.00009082315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":6.338395e-7,"about_ca_topic_score_gemma":6.104848e-7,"domain_scores_codex":[0.9988014,0.00006087198,0.0002833514,0.0003174206,0.0002181938,0.0003187693],"domain_scores_gemma":[0.9994377,0.00009633919,0.0001063593,0.0001148763,0.0000861762,0.0001584809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003595977,0.0001537903,0.0009618446,0.0004336135,0.0008062478,0.00003572981,0.1279796,0.000009160144,0.2502071,0.0003138226,0.03976758,0.5757356],"study_design_scores_gemma":[0.006049802,0.0002550527,0.0008560467,0.0001191424,0.00008577693,0.00003042857,0.002755154,0.004614273,0.3823787,0.00004588794,0.6022967,0.0005130836],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806105,0.003588854,0.003507278,0.01028395,0.0002295149,0.001316717,0.000007441667,0.0001098621,0.00034591],"genre_scores_gemma":[0.954468,0.00525902,0.005545112,0.03235451,0.0003905172,0.000159263,0.00003165995,0.00006779991,0.001724093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5752225,"threshold_uncertainty_score":0.6410953,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3164945230","doi":"10.2147/dddt.s299591","title":"A Review of Romiplostim Mechanism of Action and Clinical Applicability","year":2021,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Amgen","keywords":"Romiplostim; Thrombopoietin; Medicine; Eltrombopag; Aplastic anemia; Megakaryocyte; Thrombopoietin receptor; Platelet; Internal medicine; Immunology; Oncology; Haematopoiesis; Bone marrow; Stem cell; Immune thrombocytopenia","retraction":null,"screen_n_in":null,"score":{"opus":0.1612710011089491,"gpt":0.4099109441596687,"spread":0.2486399430507195,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008326652,0.0002765688,0.002519896,0.00006762291,0.00003123017,0.000004740461,0.00005132933,0.000168529,0.00004567342],"category_scores_gemma":[0.00004189473,0.0001895263,0.0002269772,0.0001587493,0.00006251164,0.00002358044,0.00003279458,0.0001586639,0.000002125364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002660427,"about_ca_system_score_gemma":0.0004810533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003745192,"about_ca_topic_score_gemma":4.921882e-7,"domain_scores_codex":[0.9982215,0.0002236748,0.0009068788,0.0003650076,0.0001615926,0.0001213099],"domain_scores_gemma":[0.9989321,0.0002642442,0.0004072648,0.0002223979,0.00008544583,0.00008851722],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003283782,0.0003178951,0.00002988286,0.03995551,0.0007957343,0.00001536015,0.0000374044,6.416333e-10,0.000001520607,0.00003891769,0.000138412,0.9586365],"study_design_scores_gemma":[0.001516326,0.0001887618,0.00003591309,0.09774419,0.001035786,0.00009307701,0.00001372895,0.000001488123,0.0002539947,0.0001882478,0.8986835,0.0002449563],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005120918,0.9973055,0.000343379,0.00002836086,0.00004373178,0.001695228,0.000005905456,0.00001113101,0.00005464892],"genre_scores_gemma":[0.00003193047,0.9944804,0.005050646,0.0001003153,0.00001453873,0.0001000245,0.0001109993,0.00002274997,0.0000884051],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9583915,"threshold_uncertainty_score":0.7728659,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050653904","doi":"10.2147/dddt.s46289","title":"Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases","year":2013,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Waterloo","funders":"","keywords":"Repurposing; Drug repositioning; Drug development; Intellectual property; Data sharing; Drug discovery; Computer science; Variety (cybernetics); Knowledge management; Data science; Business; Medicine; Drug; Pharmacology; Bioinformatics; Engineering; Biology; Alternative medicine; Artificial intelligence","retraction":null,"screen_n_in":null,"score":{"opus":0.2399150231530033,"gpt":0.3708165682158213,"spread":0.1309015450628181,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008673902,0.0003665874,0.001037371,0.00005764545,0.001060076,0.0001618536,0.0003792932,0.0008121245,0.00001387194],"category_scores_gemma":[0.00008976323,0.0001582635,0.000102383,0.0001842506,0.0003032392,0.0000635334,0.0002430667,0.001214215,0.00000127448],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002456819,"about_ca_system_score_gemma":0.0002706324,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005543922,"about_ca_topic_score_gemma":0.000004382194,"domain_scores_codex":[0.9984274,0.0001956801,0.0005000414,0.0004458199,0.0001313335,0.0002997486],"domain_scores_gemma":[0.9974205,0.001738386,0.0004470746,0.0002937687,0.00003832371,0.0000619413],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001581417,0.0000279999,0.00003027755,0.0008463639,0.0009405104,0.000002356491,0.005189902,0.000001792861,0.000003487429,0.00006591952,0.0001094634,0.9926238],"study_design_scores_gemma":[0.001019989,0.00005114677,0.00002181532,0.004875923,0.0005010591,0.00001910222,0.003369946,0.0002336763,0.0001755388,0.00005480105,0.9894108,0.0002662653],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004521376,0.9876363,0.005952866,0.0008430614,0.00006794223,0.004944029,0.000007904654,0.00005577282,0.00004002546],"genre_scores_gemma":[0.0007989657,0.9912491,0.003647669,0.0001102159,0.00006436701,0.001986398,0.00007636262,0.00005625078,0.002010604],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9923575,"threshold_uncertainty_score":0.8153353,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2086247967","doi":"10.2147/dddt.s36984","title":"The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol","year":2013,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Institut de Cardiologie de Montréal; Fondation Institut de Cardiologie de Montréal; Heart and Stroke Foundation of Canada","keywords":"PCSK9; LDL receptor; Kexin; Proprotein convertase; Cholesterol; Lipoprotein; Low-density lipoprotein; Endocrinology; Medicine; Internal medicine; Pharmacology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.0452173383743127,"gpt":0.2978546919823394,"spread":0.2526373536080267,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001448552,0.0005440103,0.001725766,0.0001116134,0.0003230811,0.00009055024,0.0003174479,0.0002278721,0.00001611792],"category_scores_gemma":[0.00004611522,0.000264372,0.0002575477,0.0002607734,0.0001061723,0.0000337666,0.00009626775,0.0003814179,0.00002833843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000059495,"about_ca_system_score_gemma":0.0006837782,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006431204,"about_ca_topic_score_gemma":0.00005583937,"domain_scores_codex":[0.9971843,0.0006208083,0.0007836231,0.0005706633,0.0003710259,0.0004695285],"domain_scores_gemma":[0.9980151,0.0005257933,0.0002799602,0.0007521955,0.0001222505,0.000304695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009917734,0.00002341724,0.00003175368,0.0003377556,0.001315315,0.000002762247,0.001593011,1.568552e-7,0.00008672068,0.00003422635,0.0002251218,0.9962506],"study_design_scores_gemma":[0.001600722,0.0001668994,0.0003202599,0.002673677,0.0003475884,0.00002785066,0.0001282415,0.000003749372,0.00188451,0.0001244518,0.9923944,0.0003276324],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01488606,0.9722947,0.003951164,0.001893293,0.0002056842,0.006708085,0.000009277459,0.00003260867,0.0000190945],"genre_scores_gemma":[0.001944636,0.9923994,0.002583082,0.001812728,0.0003586772,0.0005187615,0.00002139799,0.00006792544,0.0002934175],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9959229,"threshold_uncertainty_score":0.9999809,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007084442","doi":"10.2147/dddt.s14071","title":"A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCG-refractory and BCG-intolerant patients","year":2010,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Medicine; Tolerability; Refractory (planetary science); Adverse effect; Bladder cancer; Urology; Toxicity; Pharmacokinetics; Internal medicine; Maximum tolerated dose; Clinical endpoint; Gastroenterology; Surgery; Clinical trial; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.03116886744117042,"gpt":0.3167600006688397,"spread":0.2855911332276693,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002205308,0.00024685,0.000441879,0.00009967996,0.0001061341,0.00001602817,0.00007864922,0.0000608539,0.00004168862],"category_scores_gemma":[0.00001398161,0.0001510861,0.00004213485,0.00009124906,0.00008170124,0.00007458591,0.00001112937,0.00008734746,2.434367e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000462694,"about_ca_system_score_gemma":0.0002929751,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002027071,"about_ca_topic_score_gemma":0.0002661431,"domain_scores_codex":[0.9987538,0.00007042191,0.0004609244,0.0003002549,0.0001995693,0.0002150594],"domain_scores_gemma":[0.9991832,0.0002327502,0.0001749596,0.0001925734,0.000123588,0.00009288238],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.008878768,0.0217284,0.03727768,0.00006254874,0.001197869,0.0000116529,0.09580312,0.00000309097,0.07179661,0.000003977026,0.00001860756,0.7632177],"study_design_scores_gemma":[0.1058747,0.02634784,0.397004,0.000160685,0.0003113608,0.000004064525,0.00627158,0.000215134,0.4614384,0.00005083389,0.001828425,0.0004929246],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951558,0.001367514,0.00006455676,0.00006684577,0.0001258479,0.003173894,0.00002293323,0.000009776753,0.0000127914],"genre_scores_gemma":[0.9962613,0.001369052,0.001476938,0.00006685591,0.00004612296,0.0006826164,0.00002110407,0.00002839111,0.00004761114],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7627248,"threshold_uncertainty_score":0.6161114,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2886610362","doi":"10.2147/dddt.s147276","title":"Current research for a vaccine against Lassa hemorrhagic fever virus","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Public Health Agency of Canada; University of Manitoba","funders":"","keywords":"Lassa virus; Lassa fever; Arenavirus; Case fatality rate; Virology; Viral hemorrhagic fever; Medicine; Outbreak; Transmission (telecommunications); Immunology; Clinical trial; Ebola virus; Immune system; Virus; Environmental health; Population","retraction":null,"screen_n_in":null,"score":{"opus":0.3161784503176199,"gpt":0.4719851488701732,"spread":0.1558066985525533,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003039551,0.0005079415,0.001359587,0.0008452078,0.0005533208,0.0001345389,0.000218573,0.0002529222,0.00014576],"category_scores_gemma":[0.00007671877,0.0003416289,0.0002837406,0.0007642249,0.0001047922,0.0000772136,0.0001142985,0.0007584844,0.0002624972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002818544,"about_ca_system_score_gemma":0.0015251,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000888549,"about_ca_topic_score_gemma":0.000006207364,"domain_scores_codex":[0.9968103,0.0004104704,0.0006680164,0.0007330004,0.0005968941,0.0007813679],"domain_scores_gemma":[0.9981462,0.0005220013,0.0001341139,0.0003674076,0.0005279352,0.0003023597],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001491405,0.0002284115,0.000008379985,0.003797476,0.000291533,0.00001444516,0.000194369,2.028824e-8,0.00001370257,0.00001955068,0.0318318,0.9634511],"study_design_scores_gemma":[0.001573524,0.0002233773,0.00001208586,0.004671599,0.00007221473,0.0000346718,0.00001481246,0.00002478875,0.0004558977,0.00006949747,0.9924711,0.0003764282],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002215027,0.9933965,0.00128977,0.0001053289,0.0003122351,0.004291629,0.00001479359,0.00007088181,0.0002974185],"genre_scores_gemma":[0.00001985698,0.9895912,0.002929319,0.0000783835,0.0006697734,0.001476204,0.0002494466,0.0001078017,0.004877971],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9630747,"threshold_uncertainty_score":0.9999036,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085903398","doi":"10.2147/dddt.s67349","title":"Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol","year":2014,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Advanced Drug Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Curtin Health Innovation Research Institute, Curtin University; Curtin University of Technology","keywords":"Dispersity; Transdermal; Thixotropy; Drug delivery; Materials science; Probucol; Zeta potential; Polymer; Thermal analysis; Chemical engineering; Chromatography; Chemistry; Biomedical engineering; Nanotechnology; Pharmacology; Nanoparticle; Antioxidant; Organic chemistry; Polymer chemistry; Medicine; Thermal; Composite material","retraction":null,"screen_n_in":null,"score":{"opus":0.08454579430934943,"gpt":0.3811557602150955,"spread":0.296609965905746,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002434475,0.0003127477,0.0003007034,0.0001077,0.0007551224,0.00005490055,0.0002763083,0.000151802,0.0000815667],"category_scores_gemma":[0.00004365234,0.0002337414,0.00008176581,0.0001596439,0.0001084501,0.0001500029,0.00004794905,0.0002769343,0.00005121661],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005033959,"about_ca_system_score_gemma":0.0001411563,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001452222,"about_ca_topic_score_gemma":0.000003640472,"domain_scores_codex":[0.9979144,0.0005570251,0.0004334974,0.0004431673,0.0001860087,0.0004658579],"domain_scores_gemma":[0.9979517,0.001355446,0.0002077616,0.0001906258,0.0001650933,0.0001293819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001473801,0.0003164926,0.0005923632,0.00007324653,0.0006489271,0.000004164132,0.006830808,0.006840888,0.3434479,0.0009494075,0.004203678,0.6346183],"study_design_scores_gemma":[0.004931528,0.00008378585,0.0006703472,0.00002669275,0.00009037248,0.0000302187,0.000327561,0.09556923,0.3939141,0.001184005,0.5026686,0.0005036211],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.2558067,0.002925389,0.7362747,0.0009382028,0.001012782,0.002799832,0.000008646438,0.0001111134,0.0001226705],"genre_scores_gemma":[0.8780099,0.0009171408,0.1140858,0.002744799,0.0003713626,0.0008008856,0.00003303371,0.00006320879,0.002973905],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6341147,"threshold_uncertainty_score":0.9531696,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1999772350","doi":"10.2147/dddt.s32328","title":"New and emerging treatments for symptomatic tardive dyskinesia","year":2013,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Parks Canada; The Scarborough Hospital; Parkinson's Clinic of Eastern Toronto & Movement Disorders Centre; World Wildlife Fund Canada","funders":"","keywords":"Tardive dyskinesia; Tetrabenazine; Medicine; Levetiracetam; Pharmacology; Bioinformatics; Psychiatry; Dopamine; Internal medicine; Biology; Schizophrenia (object-oriented programming); Epilepsy","retraction":null,"screen_n_in":null,"score":{"opus":0.06372742804327497,"gpt":0.3200240483238522,"spread":0.2562966202805773,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000150162,0.0006583938,0.001494135,0.000234301,0.0001924835,0.00007741621,0.00008061412,0.0001563482,0.00008889887],"category_scores_gemma":[0.000007165033,0.000437449,0.0001950724,0.0001290123,0.00002073284,0.00008236295,0.00003057287,0.00008177617,0.00004390499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001127032,"about_ca_system_score_gemma":0.0005256899,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001048506,"about_ca_topic_score_gemma":3.404155e-7,"domain_scores_codex":[0.9983273,0.00006985086,0.0004528422,0.0005729564,0.0002111757,0.0003658423],"domain_scores_gemma":[0.9990281,0.0001302311,0.000222662,0.0002110339,0.00004478928,0.0003631499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004846679,0.0001006333,0.00004218734,0.001670725,0.002500251,0.00002744487,0.0003848419,1.401914e-8,0.000001805785,0.00003088413,0.001075112,0.9941176],"study_design_scores_gemma":[0.003729902,0.0001604301,0.0001378397,0.004034093,0.001728192,0.00005786023,0.00002515168,0.00001129044,0.00009940534,0.0003313056,0.9892218,0.0004627507],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005209134,0.9911972,0.003531688,0.00003515625,0.0001228685,0.004444845,0.00001102115,0.00007058062,0.00006574098],"genre_scores_gemma":[0.00002690959,0.9480874,0.04554899,0.00006823882,0.00009274863,0.001295707,0.0002278311,0.00008949086,0.004562707],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9936549,"threshold_uncertainty_score":0.9998077,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4212951396","doi":"10.2147/dddt.s330947","title":"Network Pharmacology and Molecular Docking Study of the Chinese Miao Medicine Sidaxue in the Treatment of Rheumatoid Arthritis","year":2022,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Science and Technology Program of Guizhou Province; Guizhou University; Guizhou Medical University; National Natural Science Foundation of China","keywords":"Rheumatoid arthritis; Systems pharmacology; Signal transduction; Traditional Chinese medicine; Arthritis; Molecular Pharmacology; Animal model","retraction":null,"screen_n_in":null,"score":{"opus":0.01927102335854746,"gpt":0.2823330603764326,"spread":0.2630620370178852,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008082767,0.0001688309,0.0004158604,0.0001095809,0.0002710294,0.000008415904,0.0001397899,0.00001868702,0.00008827745],"category_scores_gemma":[0.00001012567,0.00008805246,0.00003161303,0.000408937,0.0001628655,0.00002828188,0.00004658088,0.0001332224,1.737832e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000294957,"about_ca_system_score_gemma":0.00009645648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001285702,"about_ca_topic_score_gemma":0.00004726385,"domain_scores_codex":[0.9981601,0.0006276538,0.0003796306,0.0001987703,0.0004025053,0.0002313417],"domain_scores_gemma":[0.9993602,0.0002741162,0.0001136534,0.0001708079,0.00003520357,0.00004602952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003303043,0.004433908,0.3636301,0.00003128245,0.001074326,0.0002883802,0.2633127,0.0005217144,0.01893013,0.0002479176,0.00105164,0.3431748],"study_design_scores_gemma":[0.1423813,0.02414904,0.5710769,0.0009533468,0.00003251692,0.0009179788,0.06518623,0.001055641,0.04734066,0.006678822,0.1390529,0.001174676],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.919962,0.07723942,0.00001870048,0.001190125,0.00008313358,0.001447676,9.199607e-7,0.000007591145,0.00005036692],"genre_scores_gemma":[0.9064407,0.09284116,0.0001032007,0.0002673843,0.00001953294,0.0002982914,0.000003343041,0.00001291471,0.00001347002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3420002,"threshold_uncertainty_score":0.3590675,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2741826338","doi":"10.2147/dddt.s136240","title":"Antibiotic susceptibility, heteroresistance, and updated treatment strategies in <em>Helicobacter pylori</em> infection","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Metronidazole; Clarithromycin; Helicobacter pylori; Amoxicillin; Antibiotics; Antibiotic resistance; Medicine; Drug resistance; Tetracycline; Internal medicine; Microbiology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.06558470192644412,"gpt":0.3174042359082693,"spread":0.2518195339818252,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008448518,0.00123361,0.002928443,0.0007124796,0.0003929061,0.000302662,0.0002021427,0.0005847767,0.00003458289],"category_scores_gemma":[0.00003321765,0.0009042682,0.0002324025,0.0003254044,0.0003185078,0.000325367,0.0001218289,0.0005403025,0.00004244822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005207584,"about_ca_system_score_gemma":0.0005687801,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003322308,"about_ca_topic_score_gemma":0.001023187,"domain_scores_codex":[0.995828,0.0005147362,0.001244212,0.001231568,0.0003463128,0.0008351943],"domain_scores_gemma":[0.9981344,0.0001501864,0.0005947872,0.0007059198,0.0001686431,0.0002461158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005561646,0.0005310542,0.01782069,0.001929868,0.002743668,0.0001984727,0.002749658,2.98817e-7,0.00008702174,0.00002133701,0.0003346395,0.9730271],"study_design_scores_gemma":[0.005396984,0.000972402,0.06651246,0.005889544,0.000736448,0.0001469929,0.0001021921,0.000003806277,0.0001398308,0.0000545557,0.9191115,0.000933254],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2481847,0.7483077,0.00005910057,0.0001046952,0.000385343,0.002625054,0.00001685282,0.0001401145,0.0001764396],"genre_scores_gemma":[0.02039479,0.9768389,0.0008561653,0.00008755717,0.0001452693,0.0002163779,0.000352609,0.0001148724,0.0009934903],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9720939,"threshold_uncertainty_score":0.9993408,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2009241154","doi":"10.2147/dddt.s39100","title":"Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses?","year":2014,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Montelukast; Asthma; Clinical trial; Meta-analysis; Medicine; MEDLINE; Intensive care medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.405654172358753,"gpt":0.5102049939172079,"spread":0.1045508215584549,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01582807,0.0005553573,0.007877805,0.0001610497,0.0001608845,0.00007065973,0.000165167,0.0004133047,0.00005519143],"category_scores_gemma":[0.0009733191,0.0002549928,0.0009432791,0.0001885244,0.0004486293,0.00008807607,0.0001369304,0.0005389241,0.000003254319],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002277883,"about_ca_system_score_gemma":0.0005429388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001086928,"about_ca_topic_score_gemma":0.000007934882,"domain_scores_codex":[0.9849898,0.01094651,0.002822942,0.0007075654,0.0003170889,0.0002161449],"domain_scores_gemma":[0.9808525,0.01711032,0.001270992,0.0003948174,0.00009769406,0.0002736496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007700038,0.0001896086,0.002321354,0.0009368332,0.006465341,0.00002545129,0.0001721788,1.853051e-7,8.016271e-7,0.000007156932,0.00007333342,0.9890378],"study_design_scores_gemma":[0.005054018,0.0002503467,0.02440831,0.00617256,0.01218493,0.00001215385,0.0003909411,0.000009267157,0.00001674407,0.00008177296,0.950958,0.0004610225],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007673483,0.9887822,0.0006157756,0.0001078051,0.000166706,0.002601503,0.00002960819,0.0000140383,0.000008940329],"genre_scores_gemma":[0.002407373,0.9961964,0.0005672817,0.0003406572,0.0001673612,0.0001830937,0.00004753676,0.0000411634,0.00004915058],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9885767,"threshold_uncertainty_score":0.9999902,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2126469018","doi":"10.2147/dddt.s65396","title":"Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study","year":2014,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Curtin University of Technology","keywords":"Gliclazide; Deoxycholic acid; Thixotropy; Chromatography; Chemistry; Pharmacokinetics; Permeation; Pharmacology; Bile acid; Materials science; Insulin; Biochemistry; Medicine; Membrane","retraction":null,"screen_n_in":null,"score":{"opus":0.05547251103098966,"gpt":0.2617466584976248,"spread":0.2062741474666351,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003738573,0.00013729,0.0002527206,0.0001437214,0.0001022737,0.00002321196,0.00003587732,0.00004018608,0.00008702881],"category_scores_gemma":[0.00001902774,0.0001139933,0.00002833774,0.000188226,0.00002078842,0.00008730475,0.000009746364,0.00004624773,0.00001218054],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002099721,"about_ca_system_score_gemma":0.00005752323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000569396,"about_ca_topic_score_gemma":7.798254e-7,"domain_scores_codex":[0.9990692,0.00005735929,0.0003546577,0.0001945725,0.0001907884,0.0001334174],"domain_scores_gemma":[0.9995012,0.00005578886,0.0001430973,0.0001297901,0.0001048712,0.00006524445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003211155,0.0005379274,0.01509576,0.00002094917,0.00004239591,2.697759e-7,0.003362894,0.000003227538,0.9429011,0.00005298604,0.0000331104,0.03762829],"study_design_scores_gemma":[0.003681858,0.000314953,0.3591495,0.00002818645,0.00002559016,0.000002759229,0.0001875226,0.002731161,0.6295545,0.00007452117,0.004090786,0.0001586866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9426312,0.00004357993,0.05617154,0.0001000491,0.00006554704,0.0007214822,0.00000154176,0.00004267442,0.0002223576],"genre_scores_gemma":[0.9906246,0.00001816862,0.008571095,0.0002588405,0.00006970703,0.000044223,0.0001153424,0.00001517795,0.0002828425],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3440538,"threshold_uncertainty_score":0.4648511,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1993998711","doi":"10.2147/dddt.s19931","title":"Flavonoids targeting of IκB phosphorylation abrogates carcinogen-induced MMP-9 and COX-2 expression in human brain endothelial cells","year":2011,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Flavonoids in Medical Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Fonds Québécois de la Recherche sur la Nature et les Technologies","keywords":"Neuroinflammation; Phosphorylation; Signal transduction; Luteolin; Matrix metalloproteinase; Blood–brain barrier; Downregulation and upregulation; Chemistry; Cell biology; Pharmacology; Apigenin; Cancer research; Biochemistry; Biology; Inflammation; Immunology; Endocrinology; Flavonoid; Central nervous system","retraction":null,"screen_n_in":null,"score":{"opus":0.07462496248851534,"gpt":0.3088408561781034,"spread":0.2342158936895881,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001572327,0.0002084774,0.0003547147,0.0002272391,0.0001258221,0.00001555685,0.0001122925,0.0001360164,0.0002143311],"category_scores_gemma":[0.0001410643,0.0001692567,0.00003091327,0.0001786931,0.0001388398,0.00008421332,0.00005919347,0.0002793191,0.000006287426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005150693,"about_ca_system_score_gemma":0.0001701635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007963476,"about_ca_topic_score_gemma":0.000008615681,"domain_scores_codex":[0.9981983,0.0001994632,0.0004687419,0.0003518073,0.0004309613,0.0003507228],"domain_scores_gemma":[0.9991737,0.0002871617,0.0001051271,0.0001612739,0.00008243006,0.0001902961],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004725807,0.000141186,0.0141194,0.00006566002,0.0000281842,0.00001292447,0.01391728,3.6132e-7,0.944313,0.00003408456,0.0003369052,0.02655841],"study_design_scores_gemma":[0.002883425,0.0001607674,0.01777352,0.0002000082,0.00000474009,0.000001275848,0.0003839144,0.00005723082,0.9769611,0.0003707723,0.001028994,0.0001741841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963157,0.001300087,0.001145499,0.00007812588,0.00006351899,0.000696324,0.000001334006,0.0000299784,0.0003694037],"genre_scores_gemma":[0.972613,0.0005595269,0.02600702,0.0001159576,0.00004842249,0.00005125506,0.0000182663,0.00003166205,0.0005548466],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03264814,"threshold_uncertainty_score":0.690209,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2981860386","doi":"10.2147/dddt.s207856","title":"<p>Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis</p>","year":2019,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"Swedish Orphan Biovitrum; JCR Pharmaceuticals; Amicus Therapeutics; Alexion Pharmaceuticals; Ultragenyx Pharmaceutical; Sanofi; Idorsia Pharmaceuticals; Shire Human Genetic Therapies; GlaxoSmithKline","keywords":"Medicine; Renal function; Internal medicine; Cohort; Urology; Left ventricular hypertrophy; Fabry disease; Cardiology; Endocrinology; Blood pressure","retraction":null,"screen_n_in":null,"score":{"opus":0.04332455212688859,"gpt":0.2955784045651831,"spread":0.2522538524382946,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00274261,0.00065596,0.001325115,0.0006648843,0.0002350235,0.000180082,0.0003651839,0.0001808914,0.001817671],"category_scores_gemma":[0.00006476483,0.0004459863,0.0002742689,0.001090697,0.0001384075,0.0002010971,0.0001031349,0.0003119555,0.000279397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002315803,"about_ca_system_score_gemma":0.0004725668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004876595,"about_ca_topic_score_gemma":0.0001355489,"domain_scores_codex":[0.9952362,0.0006008951,0.0007730518,0.00102787,0.001509811,0.000852157],"domain_scores_gemma":[0.997757,0.0003669741,0.0002381545,0.0009001592,0.0003408366,0.0003969359],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006109332,0.0004515485,0.9603968,0.0000474662,0.005530973,0.0001424882,0.001689146,0.00002100154,0.003277321,0.00001600309,0.001428776,0.02088909],"study_design_scores_gemma":[0.01198721,0.0006399762,0.96661,0.00006697819,0.0001514078,0.00001780369,0.00007403437,0.00008392533,0.007363636,0.00001138979,0.01224827,0.0007454305],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889394,0.00411423,0.003256269,0.0003890251,0.00008998114,0.00210905,0.00001389116,0.0001315167,0.0009566574],"genre_scores_gemma":[0.9672129,0.00134337,0.001975327,0.0005490155,0.00005142164,0.0001877895,0.0003136108,0.0001037594,0.02826276],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02730611,"threshold_uncertainty_score":0.9997992,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3092098441","doi":"10.2147/dddt.s264122","title":"<p>Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cancer research; Epidermal growth factor receptor; Apoptosis; Pancreatic cancer; Mechanism (biology); Signal transduction; Epidermal growth factor; Growth factor receptor; Chemistry; Receptor; Medicine; Pharmacology; Internal medicine; Cancer; Cell biology; Biology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02250420535005674,"gpt":0.2330550398923363,"spread":0.2105508345422795,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005709067,0.0003888369,0.0006699115,0.0001822261,0.0001187051,0.00004289794,0.00008683997,0.0001493682,0.00005861752],"category_scores_gemma":[0.0000706736,0.0003336362,0.0000482669,0.0002399477,0.00007926925,0.0001339534,0.00004933809,0.0002035467,0.000001738419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004184906,"about_ca_system_score_gemma":0.0001781947,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002806375,"about_ca_topic_score_gemma":0.000003228081,"domain_scores_codex":[0.9980258,0.0001776001,0.0005621993,0.0004979342,0.0003116206,0.0004247901],"domain_scores_gemma":[0.9990573,0.0002458457,0.0002127085,0.00009279112,0.00007992671,0.0003114391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003587272,0.00005685747,0.004867543,0.000423343,0.0001456821,0.00002406852,0.007191576,0.000003597151,0.9778489,0.00009546785,0.00004104374,0.008943155],"study_design_scores_gemma":[0.002579717,0.0002479106,0.003301346,0.0002518282,0.00004201108,0.000003356548,0.0002082483,0.0003542206,0.992258,0.00004465147,0.0003355586,0.0003731386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932936,0.004047027,0.001271572,0.000392987,0.00009559911,0.0008349202,0.000009365742,0.00004136801,0.00001355564],"genre_scores_gemma":[0.988039,0.001838114,0.009362548,0.0004778597,0.00008740094,0.00010485,0.00001642728,0.00005502308,0.00001877559],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01440907,"threshold_uncertainty_score":0.9999115,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2897528830","doi":"10.2147/dddt.s172487","title":"Antioxidative stress effects of vitamins C, E, and B<sub>12</sub>, and their combination can protect the liver against acetaminophen-induced hepatotoxicity in rats","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"College of Pharmacy and Nutrition, University of Saskatchewan; University of Petra","keywords":"Acetaminophen; Oxidative stress; Pharmacology; Vitamin E; In vivo; Antioxidant; Chemistry; Hepatocyte; Glutathione; Vitamin C; Lipid peroxidation; Superoxide dismutase; Hepatoprotection; Liver injury; Biochemistry; In vitro; Enzyme; Medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.06731345294423799,"gpt":0.310410970952835,"spread":0.2430975180085971,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001651161,0.000427848,0.000454581,0.0002475948,0.0006774389,0.00005755287,0.0001935912,0.0003525192,0.0000117437],"category_scores_gemma":[0.00006738753,0.0003217516,0.0000427363,0.0003365706,0.0004463837,0.0002262572,0.00009991357,0.0005856079,0.000004463745],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008762668,"about_ca_system_score_gemma":0.0001575462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003145101,"about_ca_topic_score_gemma":0.0003410229,"domain_scores_codex":[0.9969442,0.001477027,0.0004376425,0.0005031773,0.0001973682,0.0004405513],"domain_scores_gemma":[0.9984919,0.0007570768,0.000283976,0.0001765113,0.0001446784,0.0001458417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004582859,0.0003303805,0.003851927,0.0001251073,0.000188567,0.00001101858,0.01978216,0.000002831547,0.7588941,0.0001385274,0.00003429761,0.2161828],"study_design_scores_gemma":[0.002980005,0.0003387015,0.04149559,0.0001302914,0.00002096212,0.000007375349,0.0002163386,0.001504762,0.9514976,0.0004935815,0.000936795,0.0003779952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942097,0.001327057,0.0005185351,0.0002131909,0.0003236952,0.003171351,0.00001518539,0.00005647156,0.000164791],"genre_scores_gemma":[0.994499,0.004329988,0.0001749627,0.0004518013,0.00007877432,0.0003678435,0.0000152822,0.00003172674,0.0000506733],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2158048,"threshold_uncertainty_score":0.9999235,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2975456987","doi":"10.2147/dddt.s217211","title":"<p>Hydrogels For Peptide Hormones Delivery: Therapeutic And Tissue Engineering Applications</p>","year":2019,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Hydrogels: synthesis, properties, applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Kerman University of Medical Sciences","keywords":"Self-healing hydrogels; Peptide; Hormone; Tissue engineering; Chemistry; Biomedical engineering; Internal medicine; Medicine; Biochemistry; Organic chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.03921277430519101,"gpt":0.2653786315775983,"spread":0.2261658572724073,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004689862,0.0006224553,0.00085964,0.0001523166,0.0002248116,0.00009967862,0.0003770813,0.0003581535,0.000008097689],"category_scores_gemma":[0.00001194638,0.0005283018,0.0001441692,0.0001500228,0.00007561704,0.00001177772,0.00009761339,0.0001149695,0.00003349055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004365867,"about_ca_system_score_gemma":0.0003300181,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001420174,"about_ca_topic_score_gemma":0.000001915552,"domain_scores_codex":[0.9979563,0.00009196858,0.0005585711,0.0008227727,0.0001597691,0.0004106614],"domain_scores_gemma":[0.9989051,0.0001243771,0.0002345373,0.0005207055,0.00008743686,0.0001279009],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002425792,0.00004560449,0.000001555088,0.001022007,0.0004822078,3.900856e-7,0.0001133306,0.000004120858,0.02437961,0.0001208547,0.0003069078,0.9734992],"study_design_scores_gemma":[0.0003458879,0.00006034931,0.000003334947,0.0003100141,0.000157204,0.00001901667,0.000005283961,0.00004873878,0.02654487,0.00003618074,0.9717921,0.0006770289],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000518876,0.9587726,0.03690393,0.0000324123,0.00004671887,0.003585265,0.00003075894,0.00005185304,0.00005758453],"genre_scores_gemma":[0.0007122411,0.9765565,0.01549513,0.00007593855,0.0001709303,0.00497315,0.0003693968,0.0001521164,0.001494554],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9728221,"threshold_uncertainty_score":0.9997169,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2606323667","doi":"10.2147/dddt.s117277","title":"Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Bayer Fund; Bayer","keywords":"Riociguat; Guanylate cyclase; Pulmonary hypertension; GUCY1A3; Medicine; GUCY2D; GUCY1B3; Chronic thromboembolic pulmonary hypertension; Internal medicine; Cardiology; Guanylate cyclase 2C; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.2607755154895581,"gpt":0.3896840185365592,"spread":0.1289085030470011,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003755838,0.0006139377,0.001961497,0.0002127408,0.0005987393,0.00004915344,0.0002252403,0.0002099085,0.00003184947],"category_scores_gemma":[0.00003250224,0.0003022328,0.0004961357,0.0001030863,0.0001535122,0.00006616388,0.00004051735,0.0001324187,0.00002436662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001199218,"about_ca_system_score_gemma":0.0009580226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002410678,"about_ca_topic_score_gemma":9.463961e-7,"domain_scores_codex":[0.9978768,0.0001181185,0.0005973915,0.0005577665,0.000376974,0.0004729862],"domain_scores_gemma":[0.9977487,0.0007647957,0.0003525127,0.0007188803,0.0001686938,0.0002464458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007043052,0.001415957,0.00002284685,0.001057563,0.001863847,0.0005606614,0.0001001496,2.413816e-7,0.00001650847,0.00000287369,0.0005071925,0.9937478],"study_design_scores_gemma":[0.003029739,0.0006997664,0.00008234759,0.002458267,0.0007834114,0.0002728185,0.00001564697,0.0002453926,0.0002332358,0.00003275289,0.9918524,0.0002942425],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005393152,0.9935982,0.0001091443,0.0001410463,0.0001940545,0.005300165,0.00002565055,0.0000334905,0.00005896019],"genre_scores_gemma":[0.000345241,0.9887157,0.002102213,0.0000458601,0.0001072711,0.001110846,0.0002233251,0.000083712,0.007265828],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9934536,"threshold_uncertainty_score":0.999943,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2531727627","doi":"10.2147/dddt.s99600","title":"Yellow fever vaccine-associated viscerotropic disease: current perspectives","year":2016,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Yellow fever vaccine; Medicine; Pharmacovigilance; Disease; Yellow fever; Family medicine; Incidence (geometry); Pediatrics; Adverse effect; Virology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04583121891987053,"gpt":0.3239922941463504,"spread":0.2781610752264799,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000275233,0.0007268665,0.001646429,0.0002368436,0.0001917382,0.00007676545,0.0002074322,0.0001488157,0.0005063912],"category_scores_gemma":[0.00004838556,0.0004468748,0.0004751814,0.0002188301,0.0000465975,0.00007669456,0.00005314823,0.0002762479,0.0001340857],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002744168,"about_ca_system_score_gemma":0.001275102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001757784,"about_ca_topic_score_gemma":6.79204e-7,"domain_scores_codex":[0.9973893,0.0002703216,0.0006076065,0.0007935449,0.0004239123,0.0005153051],"domain_scores_gemma":[0.9985006,0.0001613689,0.0003137182,0.0003948586,0.0001466975,0.0004826997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001982979,0.0003643866,0.0001421217,0.001472417,0.001012557,0.00004535198,0.0003771656,1.823062e-8,8.689316e-7,0.00007435246,0.004491747,0.9918207],"study_design_scores_gemma":[0.002665742,0.00004740884,0.001095957,0.01097038,0.0006155346,0.000004436482,0.0000353847,0.000003812704,0.000002743405,0.00006953333,0.9838944,0.0005946661],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001661626,0.9963735,0.0004574926,0.0001890682,0.0002721576,0.002311497,0.00002921669,0.0001256411,0.00007525924],"genre_scores_gemma":[0.0003149452,0.9936665,0.0001205545,0.00009917728,0.0003326608,0.0006051034,0.0001557431,0.0001065681,0.004598736],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9912261,"threshold_uncertainty_score":0.9997983,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2566999893","doi":"10.2147/dddt.s123386","title":"Folic acid-conjugated amphiphilic alternating copolymer as a new active tumor targeting drug delivery platform","year":2016,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; Royal Military College of Canada","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Amphiphile; Drug delivery; Chemistry; Biophysics; Conjugated system; Cancer cell; Internalization; Targeted drug delivery; Copolymer; SMA*; Biochemistry; Combinatorial chemistry; Cell; Polymer; Cancer; Organic chemistry; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02232719053644754,"gpt":0.2342142989801558,"spread":0.2118871084437082,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001002947,0.0004466945,0.0004040086,0.0001906831,0.0004396856,0.0001865778,0.0004120042,0.00006393787,0.0007578704],"category_scores_gemma":[0.0001115984,0.000318682,0.00006736851,0.0002515583,0.0001410523,0.0008469732,0.0001268433,0.0001198256,0.0006572027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001984735,"about_ca_system_score_gemma":0.0008057833,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002997025,"about_ca_topic_score_gemma":0.0000152321,"domain_scores_codex":[0.997116,0.0001757134,0.0006005376,0.0007130658,0.0005273516,0.0008673202],"domain_scores_gemma":[0.9983898,0.0004610263,0.000306015,0.0002725563,0.0001241717,0.0004463782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006314385,0.00006789887,0.0003365073,0.000007355046,0.00005829643,0.00004394411,0.003637819,0.00000387327,0.9168429,0.0001053603,0.001392806,0.07687178],"study_design_scores_gemma":[0.002920676,0.00005847003,0.0001221915,0.0001319311,0.00001119541,0.00001604027,0.0002940134,0.00005960227,0.9907604,0.001307683,0.003766948,0.0005508024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944474,0.002073384,0.001439875,0.0007466031,0.0003085341,0.0005987943,0.000007056027,0.0002760983,0.0001022869],"genre_scores_gemma":[0.9903334,0.0003152635,0.006878172,0.001193001,0.0001841676,0.00008500915,0.000006997796,0.00006674333,0.0009372763],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07632098,"threshold_uncertainty_score":0.9999265,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2743191900","doi":"10.2147/dddt.s133944","title":"Modeling the human Na<sub>v</sub>1.5 sodium channel: structural and mechanistic insights of ion permeation and drug blockade","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; University of Toronto; Western Canada Research Grid","keywords":"Molecular dynamics; Sodium channel; Chemistry; Permeation; Ion channel; Lipid bilayer; Homology modeling; Biophysics; Ion; Membrane; Sodium; Computational chemistry; Biochemistry; Biology; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.0233547755548684,"gpt":0.2384513339822457,"spread":0.2150965584273773,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002981153,0.0001923136,0.000154267,0.00006003545,0.0008621998,0.0001017237,0.000109306,0.00009986861,0.000003088776],"category_scores_gemma":[0.00001527952,0.0001408451,0.00002749635,0.00002811799,0.0001018827,0.00002091107,0.00006446922,0.00006199599,5.146279e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001011784,"about_ca_system_score_gemma":0.00004044559,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006657664,"about_ca_topic_score_gemma":0.00001835579,"domain_scores_codex":[0.999088,0.00007460556,0.0002223799,0.000305539,0.0001540827,0.0001553879],"domain_scores_gemma":[0.9994892,0.00001301209,0.0001428702,0.0001923587,0.0001036318,0.00005895877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001729533,0.000017264,0.0001140699,0.0000212141,0.00006879517,7.214504e-7,0.002832637,0.0001905213,0.9846863,0.0005553509,0.00006076664,0.01127943],"study_design_scores_gemma":[0.001386881,0.0000874781,0.002433011,0.0000356466,0.00001718736,0.00001039296,0.0002188175,0.04284029,0.9493572,0.002397552,0.0009156312,0.000299925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856161,0.001512868,0.01211907,0.0001542121,0.0002211178,0.0003202652,0.000001734475,0.00001238898,0.00004222642],"genre_scores_gemma":[0.9979959,0.001130993,0.000297056,0.00005666944,0.0001971688,0.00002425411,0.00005799149,0.00001906441,0.0002208855],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04264976,"threshold_uncertainty_score":0.6631431,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2894830330","doi":"10.2147/dddt.s167382","title":"Synthesis and anticancer activity of dimeric podophyllotoxin derivatives","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Plant-derived Lignans Synthesis and Bioactivity","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lakehead University","funders":"Institute of Botany, Chinese Academy of Sciences; National Key Research and Development Program of China; Kunming Institute of Botany, Chinese Academy of Sciences; State Key Laboratory of Phytochemistry and Plant Resources in West China; Chinese Academy of Sciences","keywords":"Podophyllotoxin; Etoposide; Chemistry; Triazole; Cytotoxicity; MTT assay; Click chemistry; Combinatorial chemistry; Stereochemistry; Cell growth; In vitro; Biochemistry; Biology; Chemotherapy; Organic chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02212688997490328,"gpt":0.2391790370952296,"spread":0.2170521471203263,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002829667,0.0001640126,0.0001988715,0.00004244591,0.0001157544,0.00001715367,0.00008165024,0.00006796864,0.00001602372],"category_scores_gemma":[0.00002607753,0.0001292074,0.00002554608,0.00006717363,0.0002552551,0.000008683931,0.00004667122,0.00003399893,0.00000124651],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000004785454,"about_ca_system_score_gemma":0.00006900262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001287662,"about_ca_topic_score_gemma":0.000005694871,"domain_scores_codex":[0.9991965,0.0001208995,0.0001267766,0.000287571,0.00009613625,0.0001720608],"domain_scores_gemma":[0.9996061,0.00007970805,0.00008872079,0.0001263541,0.00004378463,0.00005531178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002672165,0.0000628575,0.003166885,0.000008628414,0.00009918522,5.635255e-7,0.0002954577,6.074455e-8,0.8412226,0.000009198495,0.00006699302,0.1548004],"study_design_scores_gemma":[0.0002232422,0.00009140431,0.04074411,0.00002141996,0.000006027147,0.000003647925,0.00004144256,0.00001202027,0.9530734,0.0000255703,0.005578286,0.0001793603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938849,0.0009385858,0.004733258,0.00006862816,0.00003985333,0.0001630469,0.000004817388,0.000008623222,0.0001582707],"genre_scores_gemma":[0.9914957,0.001962454,0.006284064,0.00006370924,0.00005382202,0.00002543704,0.000002434504,0.00001354386,0.00009881546],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.154621,"threshold_uncertainty_score":0.5268927,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2794378246","doi":"10.2147/dddt.s130809","title":"Rucaparib: a novel PARP inhibitor for <em>BRCA</em> advanced ovarian cancer","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"PARP inhibitor; Ovarian cancer; Cancer research; Medicine; Poly ADP ribose polymerase; Chemistry; Pharmacology; Cancer; Internal medicine; Biochemistry; DNA; Polymerase","retraction":null,"screen_n_in":null,"score":{"opus":0.1120232755198394,"gpt":0.3535853993551428,"spread":0.2415621238353035,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002106494,0.002070135,0.004070671,0.0008619952,0.0007184327,0.0002935382,0.0006953277,0.001019598,0.0008414518],"category_scores_gemma":[0.0001160041,0.001719053,0.0008213613,0.001088449,0.0003497441,0.0003362486,0.0001337883,0.0008691197,0.0002746584],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001213836,"about_ca_system_score_gemma":0.003912806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001502683,"about_ca_topic_score_gemma":0.0001381522,"domain_scores_codex":[0.9921333,0.0003540996,0.002456389,0.002164615,0.001279944,0.001611618],"domain_scores_gemma":[0.99506,0.0006953867,0.001421097,0.001311708,0.0007529686,0.0007588478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001503799,0.0005456718,0.00001599402,0.004501616,0.002303943,0.00001482532,0.005527198,0.000002259548,0.001427691,0.0002535937,0.03922874,0.9446747],"study_design_scores_gemma":[0.00966324,0.0002377294,0.00002338625,0.01415059,0.0005056446,0.0001122926,0.00006424277,0.000006321678,0.001652137,0.0003634676,0.9712301,0.001990829],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008782032,0.9626936,0.0246221,0.0004677256,0.002600608,0.007617833,0.0002853411,0.0004405814,0.0003940289],"genre_scores_gemma":[0.00006040504,0.8894089,0.08951828,0.001418294,0.002415263,0.006431799,0.001137345,0.0005048276,0.009104894],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9426838,"threshold_uncertainty_score":0.999204,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1805190643","doi":"10.2147/dddt.s91116","title":"Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Institute on Drug Abuse; National Institutes of Health","keywords":"Hydrogen sulfide; Naproxen; NFKB1; Cancer research; Chemistry; Kappa; NF-κB; Colorectal cancer; Signal transduction; Cell growth; Caco-2; Cancer; Pharmacology; Medicine; Biochemistry; Internal medicine; Cell; Pathology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.04378084400248498,"gpt":0.2624685227081209,"spread":0.2186876787056359,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005532391,0.0002885679,0.0003796388,0.00009438051,0.0001767558,0.00005631329,0.00006660198,0.0001137418,0.00003525251],"category_scores_gemma":[0.0000404824,0.0002318906,0.0000313752,0.000134356,0.00007266828,0.0001641446,0.00003701951,0.0001475467,0.00001131495],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000775386,"about_ca_system_score_gemma":0.0004317602,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001013548,"about_ca_topic_score_gemma":0.00001412668,"domain_scores_codex":[0.9985045,0.0001284082,0.000301475,0.0003553393,0.0003367627,0.0003735224],"domain_scores_gemma":[0.9991336,0.0001591141,0.0001055186,0.0001192973,0.0001203827,0.0003620292],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00349952,0.0003843231,0.06544686,0.000750938,0.0005081998,0.0001844388,0.04465535,0.00003508267,0.8112632,0.0001174992,0.005574883,0.06757973],"study_design_scores_gemma":[0.003671133,0.0001201577,0.0006464215,0.0002011871,0.00003697147,0.00002225278,0.0002636068,0.00006937256,0.9804618,0.0001494929,0.0140076,0.0003500191],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9791973,0.01900296,0.0003382517,0.00019089,0.0001606443,0.0007349915,0.000001684087,0.00008111798,0.000292213],"genre_scores_gemma":[0.9918384,0.002921228,0.004031152,0.0004162561,0.0002052994,0.0001084559,0.00001982127,0.0000492588,0.0004101617],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1691986,"threshold_uncertainty_score":0.9456223,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2020239218","doi":"10.2147/dddt.s3314","title":"Troglitazone reverses the multiple drug resistance phenotype in cancer cells","year":2009,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Troglitazone; Vorinostat; Doxorubicin; Downregulation and upregulation; Cancer research; Cancer cell; P-glycoprotein; Pharmacology; Multiple drug resistance; Histone deacetylase inhibitor; K562 cells; Cancer; Biology; Drug resistance; Medicine; Peroxisome proliferator-activated receptor; Histone deacetylase; Immunology; Receptor; Internal medicine; Histone; Chemotherapy; Leukemia; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02539059993474002,"gpt":0.2494295030414408,"spread":0.2240389031067008,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005054185,0.0002304584,0.0003125613,0.00009207457,0.0001740291,0.00002585694,0.0001280883,0.00005516805,0.00006689911],"category_scores_gemma":[0.000005701441,0.0001454006,0.00004894478,0.0002662444,0.00005941737,0.00007383619,0.00000591155,0.0001826857,0.0000097696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006740881,"about_ca_system_score_gemma":0.0001868272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002220965,"about_ca_topic_score_gemma":0.0002300069,"domain_scores_codex":[0.9986866,0.00006320608,0.0003146832,0.0003178002,0.0002770933,0.0003405985],"domain_scores_gemma":[0.9994952,0.0000840425,0.00007120248,0.0002071824,0.00005136552,0.00009101111],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01291005,0.002292295,0.02167689,0.0003327263,0.0005927269,0.0005958548,0.09273767,0.00009929891,0.3859371,0.003004208,0.03099481,0.4488263],"study_design_scores_gemma":[0.008203821,0.00007347654,0.06400664,0.0006014899,0.00004681138,0.00000338474,0.001334337,0.00006508193,0.6340706,0.002155685,0.2887215,0.0007172048],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9633856,0.02415043,0.002190603,0.007254024,0.0003300092,0.001441125,0.000003612536,0.0001115324,0.001133038],"genre_scores_gemma":[0.9622042,0.006543485,0.01324345,0.001601976,0.00008339164,0.00007798321,0.00001007353,0.00002522297,0.01621023],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4481091,"threshold_uncertainty_score":0.5929264,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2059050231","doi":"10.2147/dddt.s71352","title":"Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine","year":2014,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; Aerospace Center Hospital; Manitoba Health Research Council; Bill and Melinda Gates Foundation","keywords":"Hydroxychloroquine; Medicine; Pharmacology; Internal medicine; Coronavirus disease 2019 (COVID-19)","retraction":null,"screen_n_in":null,"score":{"opus":0.02153238606918721,"gpt":0.2502908958702337,"spread":0.2287585098010465,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000683594,0.0001828843,0.0003340252,0.00008026689,0.0001476844,0.000007813413,0.00008118466,0.00005547374,0.00002702632],"category_scores_gemma":[0.00001423294,0.0001023936,0.00004264955,0.00009474375,0.00008184554,0.00003623511,0.00002022235,0.00005803297,0.000001521477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002258229,"about_ca_system_score_gemma":0.0001955585,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009497634,"about_ca_topic_score_gemma":0.000002172553,"domain_scores_codex":[0.9990546,0.00003399867,0.0003251183,0.000178834,0.0001869237,0.0002205671],"domain_scores_gemma":[0.9993112,0.0002446116,0.0001277356,0.0001407618,0.0001069533,0.00006874568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003639514,0.0005072325,0.004173705,0.0002793572,0.001239533,0.00000430431,0.01907802,0.000006731837,0.07161972,0.0005491799,0.0009054381,0.8979973],"study_design_scores_gemma":[0.00789942,0.0007029501,0.01358692,0.0001923021,0.0001061206,0.00001178042,0.0007751556,0.0004823231,0.8778451,0.0001858715,0.09793162,0.0002804313],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9699324,0.002693765,0.02585209,0.0004004823,0.0000650874,0.000877691,9.347706e-7,0.00001946252,0.0001580301],"genre_scores_gemma":[0.9606805,0.0003450329,0.03747037,0.0002129938,0.00004928137,0.00007763283,0.00001422529,0.00002157585,0.0011284],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8977168,"threshold_uncertainty_score":0.4175492,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2606957323","doi":"10.2147/dddt.s131213","title":"Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Dissolution; Dissolution testing; Materials science; Diffusion; Chemistry; Biochemical engineering; Computer science; Thermodynamics; Physics; Engineering","retraction":null,"screen_n_in":null,"score":{"opus":0.3897675016050524,"gpt":0.4523156752787801,"spread":0.06254817367372767,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00124763,0.0001465779,0.0002299298,0.0001385736,0.000258853,0.00005970976,0.0001212147,0.00009852441,0.000007358887],"category_scores_gemma":[0.00004371482,0.000137999,0.00001373616,0.00007985631,0.0001153678,0.0003250517,0.00003454831,0.0002021678,0.000001044289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000043988,"about_ca_system_score_gemma":0.0000958334,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009425568,"about_ca_topic_score_gemma":0.00003123909,"domain_scores_codex":[0.998815,0.0002784895,0.0003922879,0.0002373883,0.00008845209,0.0001883805],"domain_scores_gemma":[0.9993464,0.0002093871,0.0002040293,0.0001221864,0.00006097902,0.00005698951],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.001237097,0.0004025415,0.04564091,0.0001500785,0.00004307714,0.000008423342,0.01758363,0.001085967,0.4110607,0.0002391155,0.00004665721,0.5225018],"study_design_scores_gemma":[0.004201346,0.00003866035,0.04863251,0.0002524497,0.00002575002,0.00001033731,0.0007261615,0.4831257,0.4563894,0.004258207,0.001798436,0.0005410297],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939566,0.002544574,0.002460709,0.00008598232,0.0003349774,0.0004304243,0.000005280464,0.00001210178,0.0001693579],"genre_scores_gemma":[0.9960726,0.0005826256,0.003189984,0.00004342354,0.00003303537,0.00002928381,0.00001071756,0.000008988558,0.00002933413],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5219608,"threshold_uncertainty_score":0.5627435,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2772982640","doi":"10.2147/dddt.s142580","title":"EUREKA study – the evaluation of real-life use of a biophotonic system in chronic wound management: an interim analysis","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Laser Applications in Dentistry and Medicine","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Klox Technologies (Canada)","funders":"","keywords":"Medicine; Context (archaeology); Quality of life (healthcare); Venous leg ulcer; Wound healing; Interim analysis; Prospective cohort study; Adverse effect; Internal medicine; Surgery; Clinical trial; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.1796337183040056,"gpt":0.3932029522171656,"spread":0.21356923391316,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00263684,0.0001352596,0.0003654428,0.0002515459,0.0001625621,0.00003791757,0.0002228886,0.00003783229,0.00003535811],"category_scores_gemma":[0.00002705219,0.00008958635,0.00004111107,0.0003247924,0.0001145071,0.0001128255,0.00004847033,0.00007917744,0.00000194429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001525265,"about_ca_system_score_gemma":0.0002301862,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001946859,"about_ca_topic_score_gemma":0.0002148177,"domain_scores_codex":[0.9984574,0.000217581,0.0004677506,0.0002604216,0.0004683453,0.0001285558],"domain_scores_gemma":[0.9985923,0.0000559157,0.0003160156,0.0008102028,0.0001662008,0.00005941336],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003391298,0.004190116,0.6273185,0.001128838,0.01347636,0.00006070824,0.04936982,0.0006466764,0.02100899,0.001195052,0.0003031584,0.2779105],"study_design_scores_gemma":[0.005883209,0.0002206317,0.9767949,0.0002467201,0.001288633,0.000004862451,0.00290035,0.003358048,0.007742563,0.00002977424,0.001378139,0.0001521512],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956793,0.0004755655,0.001554974,0.00005761846,0.00005090519,0.001992187,0.000001755703,0.00001350111,0.0001742221],"genre_scores_gemma":[0.9975038,0.0007230169,0.001074382,0.00002012746,0.00002163243,0.0002744208,0.00002838112,0.00001044586,0.0003438189],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3494765,"threshold_uncertainty_score":0.3653225,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3014583199","doi":"10.2147/dddt.s217010","title":"<p>The Efficacy of N-Butylphthalide and Dexamethasone Combined with Hyperbaric Oxygen on Delayed Encephalopathy After Acute Carbon Monoxide Poisoning</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Hyperbaric oxygen; Carbon monoxide poisoning; Dexamethasone; Medicine; Anesthesia; Carbon monoxide; Encephalopathy; Oxygen; Pharmacology; Chemistry; Internal medicine; Poison control; Emergency medicine; Organic chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01183447713079113,"gpt":0.210700026782049,"spread":0.1988655496512578,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003492176,0.0003801418,0.0003587831,0.0000453815,0.0001128357,0.00004518307,0.0002236707,0.0001292303,0.000008844955],"category_scores_gemma":[0.00002600995,0.0002631589,0.00005989359,0.0001974449,0.0001380829,0.000008469852,0.00007630917,0.0001260788,0.000002350597],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001325237,"about_ca_system_score_gemma":0.0001549551,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006236005,"about_ca_topic_score_gemma":0.000009967765,"domain_scores_codex":[0.9982955,0.0001746453,0.0003465964,0.0005624235,0.0002658192,0.0003550302],"domain_scores_gemma":[0.9992014,0.00008982873,0.0001436986,0.0002877039,0.00007428019,0.0002030753],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007360058,0.0001355053,0.003316144,0.00001850769,0.0006419895,0.00005569194,0.002769903,0.00003535403,0.9731729,0.00003845458,0.0002540179,0.01220145],"study_design_scores_gemma":[0.004520453,0.00171986,0.01966091,0.00004707649,0.00007625995,0.00002726356,0.0001210751,0.0002227002,0.9593872,0.00002768713,0.01355907,0.0006304829],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935504,0.004405796,0.0007647951,0.0004426622,0.00003593347,0.0005547755,0.000005981636,0.00002531993,0.0002143985],"genre_scores_gemma":[0.9931659,0.001431376,0.003843539,0.001050818,0.00006808437,0.0001123931,0.00003434702,0.00005206285,0.0002415422],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01634476,"threshold_uncertainty_score":0.9999821,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2116491845","doi":"10.2147/dddt.s90170","title":"Therapeutic designed poly (lactic-co-glycolic acid) cylindrical oseltamivir phosphate-loaded implants impede tumor neovascularization, growth and metastasis in mouse model of human pancreatic carcinoma","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"PLGA; Neovascularization; Pancreatic cancer; Metastasis; Cancer research; Irinotecan; Medicine; In vivo; Angiogenesis; Pharmacology; Colorectal cancer; Pathology; Chemistry; In vitro; Cancer; Internal medicine; Biology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.04500067962431849,"gpt":0.2832978414799919,"spread":0.2382971618556735,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003955256,0.0002685071,0.0003378327,0.0001436576,0.0001116123,0.00004882691,0.0001456035,0.00008012819,0.000003986099],"category_scores_gemma":[0.00002126111,0.0002263398,0.00004673169,0.0001433019,0.00008949558,0.00002181274,0.00004769869,0.00007923144,0.000001270809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004110235,"about_ca_system_score_gemma":0.0003863103,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002012862,"about_ca_topic_score_gemma":0.00003723372,"domain_scores_codex":[0.9984431,0.0002035343,0.000322843,0.0004034975,0.0002609605,0.0003661245],"domain_scores_gemma":[0.9993899,0.00002559734,0.0001028413,0.0001980039,0.0000795207,0.0002041792],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00201327,0.0003977419,0.04412458,0.00004655595,0.0006509381,0.00002179798,0.002587642,0.00001174471,0.9293048,0.00009373944,0.00004463086,0.02070254],"study_design_scores_gemma":[0.00468167,0.0003123881,0.00439563,0.00000979801,0.00002606204,0.00001173914,0.0001336581,0.0002309138,0.9895337,0.0003737836,0.00003561929,0.0002550631],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9798664,0.0129256,0.006545084,0.00002810631,0.00001117006,0.0005504349,0.00001417088,0.0000122648,0.00004669584],"genre_scores_gemma":[0.995763,0.0009401682,0.002772984,0.0001046961,0.00001573544,0.0001343642,0.00009663984,0.00003530407,0.000137128],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06022885,"threshold_uncertainty_score":0.922987,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2891907584","doi":"10.2147/dddt.s172538","title":"Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Parasitic Diseases Research and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Institut National de la Santé et de la Recherche Médicale","keywords":"Nasopharyngeal carcinoma; In vivo; Cytotoxic T cell; Medicine; Cancer research; Cancer; Pharmacology; Cytotoxicity; In vitro; Immunology; Biology; Radiation therapy; Internal medicine; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.03305226841364001,"gpt":0.2948139527346176,"spread":0.2617616843209776,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001988232,0.0002067343,0.0002395609,0.0001326272,0.0001556497,0.00005686711,0.00003097972,0.00004374597,0.00005650666],"category_scores_gemma":[0.00001194117,0.0001649484,0.00002369976,0.000170123,0.0001316771,0.0002045257,0.00002213981,0.00008789403,0.0000218123],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008329628,"about_ca_system_score_gemma":0.0002381364,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004609209,"about_ca_topic_score_gemma":0.00001206159,"domain_scores_codex":[0.9987234,0.00009576926,0.0002454429,0.0003508356,0.0002614013,0.0003231363],"domain_scores_gemma":[0.9995311,0.00005511336,0.00004876246,0.00009873119,0.00008706342,0.0001792363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01712136,0.008066347,0.2702954,0.0005841246,0.0006788979,0.002328927,0.03874412,6.056609e-7,0.5871537,0.001283366,0.007994422,0.06574871],"study_design_scores_gemma":[0.008716801,0.0003789537,0.04069148,0.0001115032,0.0000144013,0.00005146192,0.000137514,0.00005733917,0.9479403,0.0006846744,0.00102102,0.0001945399],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961167,0.001582815,0.0001848963,0.0004116982,0.00004134602,0.001012382,0.000005264313,0.00003601776,0.0006088595],"genre_scores_gemma":[0.994957,0.0009663268,0.002861484,0.0004593022,0.0001088128,0.0001697032,0.00003267923,0.00002034155,0.0004242919],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3607866,"threshold_uncertainty_score":0.6726399,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2890671849","doi":"10.2147/dddt.s168878","title":"Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Biochemical Acid Research Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Guangzhou University; National Natural Science Foundation of China","keywords":"Peripheral neuropathy; Medicine; Peripheral; Diabetic neuropathy; Lipoic acid; Alpha-Lipoic Acid; Diabetes mellitus; Pharmacology; Surgery; Internal medicine; Endocrinology; Chemistry; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02919413509333874,"gpt":0.2734795362707481,"spread":0.2442854011774094,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002600077,0.0006080936,0.0007499062,0.00008049783,0.0002490182,0.00008229939,0.0002806315,0.0001927917,0.000005577348],"category_scores_gemma":[0.00001859844,0.0003606261,0.0001103231,0.0001576098,0.0002760043,0.000007469792,0.00008837182,0.0001597034,0.000003953686],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003532247,"about_ca_system_score_gemma":0.0003144689,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":5.659621e-7,"about_ca_topic_score_gemma":0.000002059777,"domain_scores_codex":[0.9979449,0.0001989275,0.0003339308,0.0007392804,0.0002802768,0.0005026694],"domain_scores_gemma":[0.9990743,0.00006227489,0.0001978759,0.0002987416,0.0002353854,0.000131354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002729608,0.0004240769,0.0003023444,0.001901445,0.001469716,0.000003830287,0.0002839346,1.890063e-7,0.0005282579,0.000007434602,0.0004455986,0.9919035],"study_design_scores_gemma":[0.003642283,0.005022002,0.0002177214,0.001257016,0.0001579031,0.000005559678,0.00001655376,0.000004824203,0.007381501,0.00003217788,0.9812755,0.0009869493],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0154014,0.9783347,0.003132682,0.00002541535,0.00007173726,0.002970791,0.00002222689,0.00002720826,0.00001386425],"genre_scores_gemma":[0.003868563,0.9879288,0.00556621,0.000110156,0.0001265658,0.001348362,0.0006297625,0.0001173462,0.0003042038],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9909166,"threshold_uncertainty_score":0.9998845,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3177211387","doi":"10.2147/dddt.s304708","title":"Network Pharmacology Analysis of the Mechanisms of Compound Herba Sarcandrae (Fufang Zhongjiefeng) Aerosol in Chronic Pharyngitis Treatment","year":2021,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Natural Science Foundation of China","keywords":"KEGG; Signal transduction; Computational biology; Pharmacology; Receptor; G protein-coupled receptor; Biology; Chemistry; Gene; Gene expression; Gene ontology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.03019942623124172,"gpt":0.2810780049760161,"spread":0.2508785787447744,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003372787,0.0001767093,0.0006138921,0.0001599393,0.0001042784,0.00001428595,0.00009906288,0.00005007946,0.0003514004],"category_scores_gemma":[0.000005686611,0.0001228185,0.0001279327,0.0008257318,0.0001230415,0.00004592042,0.00003836701,0.00009882594,0.000001398993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001849417,"about_ca_system_score_gemma":0.0006610593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009078693,"about_ca_topic_score_gemma":0.0002840234,"domain_scores_codex":[0.9984912,0.0002777684,0.0004033242,0.0002451807,0.0002637699,0.000318776],"domain_scores_gemma":[0.999352,0.0001801176,0.0001131061,0.000180927,0.00009372018,0.0000801181],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002279455,0.001720362,0.04530013,0.0001424145,0.0150168,0.000371874,0.01277654,0.001126795,0.6950597,0.001679305,0.00112983,0.2233969],"study_design_scores_gemma":[0.00766746,0.0003250521,0.01506507,0.000216437,0.00007563704,0.00002345672,0.0003559077,0.000760061,0.9701318,0.0006690508,0.004518233,0.0001918301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9559048,0.04142638,0.001340985,0.0004756323,0.0001042635,0.0005942361,0.00000619614,0.00001329822,0.0001342024],"genre_scores_gemma":[0.9536799,0.04380567,0.001925446,0.0001582679,0.00002725235,0.00005240072,0.00003266677,0.00001537537,0.0003030932],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2750722,"threshold_uncertainty_score":0.5008394,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2780401732","doi":"10.2147/dddt.s144602","title":"Intra-articular collagenase injection increases range of motion in a rat knee flexion contracture model","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Dupuytren's Contracture and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Canadian Institutes of Health Research; University of Ottawa","keywords":"Collagenase; Contracture; Capsule; Range of motion; Muscle contracture; Microbial collagenase; Medicine; Knee Joint; Joint capsule; Chemistry; Extracellular matrix; Anatomy; Pathology; Surgery; Biology; Enzyme; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02790962796067044,"gpt":0.2686505897946792,"spread":0.2407409618340087,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003139152,0.0001971272,0.0003450506,0.0001408458,0.000167706,0.00004575193,0.00005658937,0.000101379,0.00002151319],"category_scores_gemma":[0.0000447923,0.0001470212,0.00004568761,0.00005852221,0.00005304848,0.0002072829,0.00001311588,0.00009287057,0.000003610973],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006004914,"about_ca_system_score_gemma":0.000140633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009167544,"about_ca_topic_score_gemma":0.00005185087,"domain_scores_codex":[0.999047,0.00006267373,0.0002782678,0.0002324556,0.0001927189,0.000186892],"domain_scores_gemma":[0.9993809,0.00005084323,0.0001675464,0.0002332285,0.00007496763,0.0000924652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01902703,0.003426236,0.2294891,0.0001882597,0.001090611,0.0004404082,0.0144999,0.0005997794,0.03726431,0.0002956361,0.0007110831,0.6929677],"study_design_scores_gemma":[0.03294874,0.0006628179,0.3950046,0.0005097615,0.0002024255,0.00007584454,0.0002632918,0.00663811,0.5594919,0.002143648,0.00142779,0.0006311243],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992978,0.001416832,0.004244125,0.0002478599,0.00007036571,0.0008493523,0.000002009945,0.00002658499,0.0001648237],"genre_scores_gemma":[0.9963813,0.0004767005,0.002433531,0.0002097891,0.00003040972,0.00007186336,0.00002511004,0.00001724687,0.0003540687],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6923366,"threshold_uncertainty_score":0.599535,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1981220884","doi":"10.2147/dddt.s34976","title":"Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib","year":2012,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Cholesterylester transfer protein; Dyslipidemia; Medicine; Cholesterol; Pharmacology; Lipoprotein; Bioinformatics; Internal medicine; Disease; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.09489177903714113,"gpt":0.3135815514196455,"spread":0.2186897723825044,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002123576,0.0007879022,0.002264749,0.0003144383,0.0002057897,0.00005980023,0.0001484899,0.0005330748,0.000030292],"category_scores_gemma":[0.00001220553,0.0005240252,0.0007352885,0.0002276572,0.00005434031,0.00009711752,0.00001849323,0.0005513707,0.00004044919],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001730025,"about_ca_system_score_gemma":0.0007581651,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004643248,"about_ca_topic_score_gemma":0.000001406101,"domain_scores_codex":[0.9968942,0.0002950283,0.0008872402,0.0006944822,0.0005358881,0.0006931809],"domain_scores_gemma":[0.9987602,0.0001343166,0.000136684,0.0005284362,0.00007370159,0.000366698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001678596,0.0001579181,0.000003533656,0.007169389,0.0008194345,0.00000845012,0.0004812852,2.844087e-8,0.000006979873,0.00009230823,0.0002448814,0.9908479],"study_design_scores_gemma":[0.002524829,0.0002512059,0.00001341345,0.008517007,0.0004391464,0.0000402347,0.00001375497,2.935899e-7,0.001693872,0.00004596543,0.9858505,0.0006097762],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003652883,0.9836342,0.004677007,0.0001699429,0.0003053598,0.01058574,0.000009799307,0.00008996431,0.0001626702],"genre_scores_gemma":[0.00028863,0.9884125,0.004203196,0.0003090283,0.001246291,0.003849908,0.0001180663,0.0001943826,0.001377973],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9902381,"threshold_uncertainty_score":0.9997211,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2616264501","doi":"10.2147/dddt.s130909","title":"Ten years of clinical experience with biosimilar human growth hormone: a review of safety data","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Children’s Health Research Institute","funders":"","keywords":"Biosimilar; Medicine; Adverse effect; Patient safety; Clinical trial; Safety profile; Pharmacology; Intensive care medicine; Internal medicine; Health care","retraction":null,"screen_n_in":null,"score":{"opus":0.2994236157995498,"gpt":0.437390202776585,"spread":0.1379665869770352,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002286528,0.0005385101,0.003832569,0.0002115853,0.000132282,0.0000196913,0.0009586753,0.0002767898,0.0000325488],"category_scores_gemma":[0.0002134286,0.0003573729,0.0002574015,0.0002748267,0.0004234704,0.0001844753,0.0002292464,0.0004338545,0.000006164787],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002698914,"about_ca_system_score_gemma":0.001204661,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001472141,"about_ca_topic_score_gemma":5.875869e-7,"domain_scores_codex":[0.9958121,0.0002917583,0.002213137,0.00077484,0.0005919248,0.0003162482],"domain_scores_gemma":[0.9961155,0.0002640497,0.001624078,0.001558581,0.0002145634,0.0002232372],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002045003,0.0002047769,0.0005992262,0.02029443,0.0007672707,0.00004217846,0.0004444514,7.846186e-10,0.000004437963,0.00001772929,0.002854639,0.9745663],"study_design_scores_gemma":[0.001436707,0.0003740898,0.003186837,0.06176889,0.0005178023,0.00003150443,0.00002196105,3.071891e-7,0.00007832434,0.000005942468,0.932144,0.0004336146],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005826107,0.9969521,0.00008965881,0.00004204315,0.00007447702,0.001858013,0.00004072694,0.00002646659,0.000333922],"genre_scores_gemma":[0.0002112919,0.9942087,0.004488132,0.0001812428,0.00008269479,0.00007022887,0.0004953516,0.0000703816,0.000192006],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9741327,"threshold_uncertainty_score":0.9998878,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3026086046","doi":"10.2147/dddt.s242514","title":"<p>A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; University of British Columbia; Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada; Queen's University; Russian Foundation for Basic Research","keywords":"Triple-negative breast cancer; Cancer research; Viability assay; Breast cancer; Apoptosis; Cancer; Medicine; Biology; Chemistry; Internal medicine; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01372272287753717,"gpt":0.2355998324564319,"spread":0.2218771095788947,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005774595,0.0002966317,0.0004443718,0.00005062584,0.00009160276,0.00003960853,0.0001345444,0.0001153417,0.00003168434],"category_scores_gemma":[0.00005103643,0.0002647261,0.00004062376,0.000227382,0.0001441074,0.00003554745,0.0000586405,0.0000893496,5.758028e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003375239,"about_ca_system_score_gemma":0.0002258589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002276434,"about_ca_topic_score_gemma":0.0001002911,"domain_scores_codex":[0.998459,0.0001367791,0.0003994451,0.0005019105,0.0001934408,0.0003094169],"domain_scores_gemma":[0.9993376,0.00003354769,0.0002025704,0.0001397223,0.0001143354,0.0001722527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001838079,0.000148464,0.004976808,0.0001506625,0.0001765228,0.000002471123,0.003651723,0.000004045724,0.6766009,0.0001148196,0.0006032489,0.3117323],"study_design_scores_gemma":[0.005252216,0.0001224216,0.05351997,0.00003873854,0.00001737965,0.000002803859,0.0001115486,0.0001106402,0.9261796,0.0002997362,0.01398932,0.0003556073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8418351,0.1571344,0.0002442147,0.0001349234,0.00005867828,0.0004997841,0.0000333194,0.00001092367,0.00004862607],"genre_scores_gemma":[0.908268,0.09024146,0.000913927,0.0002801187,0.00004794947,0.0001010539,0.00003388512,0.00002492107,0.00008873385],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3113767,"threshold_uncertainty_score":0.9999805,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2548371687","doi":"10.2147/dddt.s119214","title":"Evaluating the cytotoxic effects of the water extracts of four anticancer herbs against human malignant melanoma cells","year":2016,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Flavonoids in Medical Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Saskatchewan; Queen's University","funders":"College of Pharmacy and Nutrition, University of Saskatchewan","keywords":"Cytotoxicity; Herb; Traditional medicine; Cytotoxic T cell; Melanoma; Cancer cell; Cancer; Medicine; Medicinal herbs; Pharmacology; Chemistry; Biology; In vitro; Cancer research; Internal medicine; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.0755976652955106,"gpt":0.3469543211764928,"spread":0.2713566558809822,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002352881,0.0001666586,0.0002990346,0.00006202011,0.0001610394,0.00001097906,0.0002659021,0.00006753053,0.0001055591],"category_scores_gemma":[0.0001852049,0.00005262568,0.00006488412,0.0001143099,0.0003327184,0.00003850924,0.00008483307,0.0001538956,0.000009645302],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005024124,"about_ca_system_score_gemma":0.0002495949,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005187095,"about_ca_topic_score_gemma":0.000001295028,"domain_scores_codex":[0.9978153,0.0003872482,0.0003846557,0.00022998,0.000831434,0.000351398],"domain_scores_gemma":[0.9984725,0.0008549365,0.0001081635,0.0003466745,0.0001234312,0.00009433817],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001664342,0.00007327119,0.001111589,0.00009895755,0.0001067875,0.000009836053,0.001885729,7.346037e-7,0.8786306,0.00002501333,0.0001628979,0.1177282],"study_design_scores_gemma":[0.002133951,0.0002559568,0.009565443,0.0007428445,0.00001412402,0.000002076216,0.00004236842,0.00003736834,0.9860929,0.0002738478,0.0007414958,0.00009768582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963256,0.0005748688,0.0005898743,0.001104911,0.0001196036,0.001134107,4.799258e-7,0.00001184424,0.0001386931],"genre_scores_gemma":[0.9947688,0.0007463884,0.001931661,0.0003072193,0.00005618942,0.00007535283,8.17624e-7,0.0000252824,0.00208832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1176305,"threshold_uncertainty_score":0.2146013,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1856761374","doi":"10.2147/dddt.s88845","title":"Paget’s disease of bone: an osteoimmunological disorder?","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Bone health and treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Amgen Canada; Université Laval; Arthritis Society; Eli Lilly and Company; Amgen","keywords":"Osteoimmunology; RANKL; Osteoprotegerin; Medicine; Immunology; Proinflammatory cytokine; Osteoclast; Bone disease; Osteoporosis; Bone resorption; Cancer research; Pathology; Internal medicine; Inflammation; Receptor; Activator (genetics)","retraction":null,"screen_n_in":null,"score":{"opus":0.1686114903308565,"gpt":0.3773982073769787,"spread":0.2087867170461221,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005872641,0.0005305461,0.001891235,0.0002168758,0.0001158348,0.00002037857,0.0001134499,0.0002342747,0.0000715726],"category_scores_gemma":[0.00002881555,0.0003390367,0.0001740171,0.0002262348,0.0001025319,0.00006623996,0.00004196507,0.0002689239,0.00005936933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008610921,"about_ca_system_score_gemma":0.001649606,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001686461,"about_ca_topic_score_gemma":0.000002814469,"domain_scores_codex":[0.9976687,0.000314498,0.0007768862,0.0004953477,0.000355155,0.0003894011],"domain_scores_gemma":[0.9984581,0.0001085595,0.0003193387,0.0004283627,0.0001003867,0.0005852179],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004294295,0.0005867855,0.0005312226,0.002444838,0.0003071871,0.00006298621,0.000402083,2.610488e-8,3.210901e-7,0.00001815061,0.0002527687,0.9949642],"study_design_scores_gemma":[0.002106206,0.0002398363,0.0008436566,0.002458417,0.0003439553,0.000034642,0.00001821643,7.158069e-7,0.000003414186,0.000110482,0.9935041,0.0003363614],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00265901,0.99485,0.00008503209,0.00006130933,0.0001108872,0.00206244,0.00001534175,0.00007174003,0.00008426065],"genre_scores_gemma":[0.000332718,0.9929274,0.00369025,0.0001020359,0.00003252875,0.0003279985,0.0006728865,0.00006256801,0.001851671],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9946278,"threshold_uncertainty_score":0.9999062,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}